Cisco
CSCO
Alibaba
BABA
Disney
DIS
4
Apple
AAPL
5
Qualcomm
QCOM
Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company, which engages in the development and commercialization of novel cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company was founded on October 22, 1991 and is headquartered in Houston, TX.